Search Results

Displaying Results 1-1 of 1 "'PDSB'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

Jan 12, 2026, 10:35 ET Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

(NASDAQ: CGON), Zentalis Pharmaceuticals (NASDAQ: ZNTL), ArriVent BioPharma (NASDAQ: AVBP), and PDS Biotechnology (NASDAQ: PDSB).  

More news about: USA News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.